The Use of Dynamic Positron Emission Tomography Imaging for Evaluating the Carcinogenic Progression of Intestinal Metaplasia to Esophageal Adenocarcinoma

REFERENCES

• Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. Jama-Journal of the American Medical Association 1991; 265(10)1287–1289
   PubMed Web of Science ®Google Scholar
• Pera M., Cameron A. J., Trastek V. F., Carpenter H. A., Zinsmeister A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104(2)510–513
   PubMed Web of Science ®Google Scholar
• Farrow D. C., Vaughan T. L. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes & Control 1996; 7(3)322–327
   PubMed Web of Science ®Google Scholar
• Pera M., Manterola C., Vidal O., Grande L. Epidemiology of esophageal adenocarcinoma. J. Surg. Oncol. 2005; 92(3)151–159
   PubMed Web of Science ®Google Scholar
• Tew W. P., Kelsen D. P., Ilson D. H. Targeted therapies for esophageal cancer. Oncologist 2005; 10(8)590–601
   PubMed Web of Science ®Google Scholar
• Enzinger P. C., Mayer R. J. Esophageal cancer. N. Engl. J. Med. 2003; 349(23)2241–2252
   PubMed Web of Science ®Google Scholar
• Bailey T., Biddlestone L., Shepherd N., Barr H., Warner P., Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence—Correlation with disease progression and dedifferentiation. American Journal of Pathology 1998; 152(1)135–144
   PubMed Web of Science ®Google Scholar
• Altorki N. K., Oliveria S., Schrump D. S. Epidemiology and molecular biology of Barrett's adenocarcinoma. Seminars in Surgical Oncology 1997; 13(4)270–280
   PubMed Web of Science ®Google Scholar
• Cameron A. J. Barrett's esophagus: Does the incidence of adenocarcinoma matter?. American Journal of Gastroenterology 1997; 92(2)193–194
   PubMed Web of Science ®Google Scholar
• Isolauri J., Luostarinen M., Isolauri E., Reinikainen P., Viljakka M., Keyrilainen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. American Journal of Gastroenterology 1997; 92(1)37–41
   PubMed Web of Science ®Google Scholar
• Katzka D. A. Barrett's esophagus: surveillance and treatment. Gastroenterology Clinics of North America 2002; 31(2)481–497
   PubMed Web of Science ®Google Scholar
• Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 1992; 33(11)1972–1980
   PubMed Web of Science ®Google Scholar
• Spaepen K., Stroobants S., Dupont P., Bormans G., Balzarini J., Verhoef G., et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?. Eur. J. Nucl. Med. Mol. Imaging. 2003; 30(5)682–688
   PubMed Web of Science ®Google Scholar
• Bhargava P., Reich P., Alavi A., Zhuang H. Radiation-induced esophagitis on FDG PET imaging. Clin. Nucl. Med. 2003; 28(10)849–850
   PubMed Web of Science ®Google Scholar
• Bakheet S. M., Amin T., Alia A. G., Kuzo R., Powe J. F-18 FDG uptake in benign esophageal disease. Clin. Nucl. Med. 1999; 24(12)995–997
   PubMed Web of Science ®Google Scholar
• Kamel E. M., Thumshirn M., Truninger K., Schiesser M., Fried M., Padberg B., et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J. Nucl. Med. 2004; 45(11)1804–1810
   PubMed Web of Science ®Google Scholar
• Flamen P., Lerut A., Van Cutsem E., Cambier J. P., Maes A., De Wever W., et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J. Thorac. Cardiovasc. Surg. 2000; 120(6)1085–1092
   PubMed Web of Science ®Google Scholar
• Block M. I., Patterson G. A., Sundaresan R. S., Bailey M. S., Flanagan F. L., Dehdashti F., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac. Surg. 1997; 64(3)770–776
   PubMed Web of Science ®Google Scholar
• Flanagan F. L., Dehdashti F., Siegel B. A., Trask D. D., Sundaresan S. R., Patterson G. A., et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am. J. Roentgenol. 1997; 168(2)417–424
   PubMed Web of Science ®Google Scholar
• Fukunaga T., Okazumi S., Koide Y., Isono K., Imazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J. Nucl. Med. 1998; 39(6)1002–1007
   PubMed Web of Science ®Google Scholar
• Chen X. X., Ding Y. W., Yang G. Y., Bondoc F., Lee M. J., Yang C. S. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000; 21(2)257–263
   PubMed Web of Science ®Google Scholar
• Buttar N. S., Wang K. K., Leontovich O., Westcott J. Y., Pacifico R. J., Anderson M. A., et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002; 122(4)1101–1112
   PubMed Web of Science ®Google Scholar
• Goldstein S. R., Yang G. Y., Curtis S. K., Reuhl K. R., Liu B. C., Mirvish S. S. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997; 18(11)2265–2270
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F., Horton P. F., Pope C. E. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58(2)163–174
   PubMedGoogle Scholar
• Hetzel D. J., Dent J., Reed W. D., Narielvala F. M., Mackinnon M., Mccarthy J. H., et al. Healing and Relapse of Severe Peptic Esophagitis After Treatment with Omeprazole. Gastroenterology 1988; 95(4)903–912
   PubMed Web of Science ®Google Scholar
• Daley J. M., Shearer J. D., Mastrofrancesco B., Caldwell M. D. Glucose metabolism in injured tissue: a longitudinal study. Surgery 1990; 107(2)187–192
   PubMed Web of Science ®Google Scholar
• Tischler M. E., Fagan J. M. Response to trauma of protein, amino acid, and carbohydrate metabolism in injured and uninjured rat skeletal muscles. Metabolism 1983; 32(9)853–868
   PubMed Web of Science ®Google Scholar
• Nelson K. M., Turinsky J. Effect of insulin on glucose and amino acid uptake by skeletal muscle following burn injury. Studies with 2-deoxyglucose and alpha-aminoisobutyric acid. JPEN J. Parenter Enteral. Nutr. 1982; 6(1)3–8
   PubMed Web of Science ®Google Scholar
• Nelson K. M., Turinsky J. Local effect of burn on skeletal muscle insulin responsiveness. J. Surg. Res. 1981; 31(4)288–297
   PubMed Web of Science ®Google Scholar
• Shearer J. D., Amaral J. F., Caldwell M. D. Glucose metabolism of injured skeletal muscle: the contribution of inflammatory cells. Circ. Shock 1988; 25(3)131–138
   PubMedGoogle Scholar
• Weisdorf D. J., Craddock P. R., Jacob H. S. Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis. Blood 1982; 60(4)888–893
   PubMed Web of Science ®Google Scholar
• Jankowski J. Gene-Expression in Barretts Mucosa—Acute and Chronic Adaptive Responses in the Esophagus. Gut 1993; 34(12)1649–1650
   PubMed Web of Science ®Google Scholar
• Prach A. T., MacDonald T. A., Hopwood D. A., Johnston D. A. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?. Lancet 1997; 350(9082)933
   PubMed Web of Science ®Google Scholar
• Yamada S., Kubota K., Kubota R., Ido T., Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J. Nucl. Med. 1995; 36(7)1301–1306
   PubMed Web of Science ®Google Scholar
• Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 1992; 33(11)1972–1980
   PubMed Web of Science ®Google Scholar
• Reinhardt M. J., Kubota K., Yamada S., Iwata R., Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J. Nucl. Med. 1997; 38(2)280–287
   PubMed Web of Science ®Google Scholar